These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 8358736

  • 1. Role of chromosome 9 in human bladder cancer.
    Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA.
    Cancer Res; 1993 Sep 01; 53(17):4066-70. PubMed ID: 8358736
    [Abstract] [Full Text] [Related]

  • 2. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 3. Frequent association of p53 gene mutation in invasive bladder cancer.
    Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M.
    Cancer Res; 1992 Mar 15; 52(6):1393-8. PubMed ID: 1540947
    [Abstract] [Full Text] [Related]

  • 4. Two molecular pathways to transitional cell carcinoma of the bladder.
    Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R.
    Cancer Res; 1994 Feb 01; 54(3):784-8. PubMed ID: 8306342
    [Abstract] [Full Text] [Related]

  • 5. p53 mutations and prognosis in bladder tumors.
    Uchida T, Wada C, Ishida H, Wang C, Egawa S, Yokoyama E, Kameya T, Koshiba K.
    J Urol; 1995 Apr 01; 153(4):1097-104. PubMed ID: 7869472
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
    Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D.
    Cancer Res; 2003 Nov 15; 63(22):7652-6. PubMed ID: 14633685
    [Abstract] [Full Text] [Related]

  • 10. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K.
    Int J Oncol; 2002 Jan 15; 20(1):107-15. PubMed ID: 11743649
    [Abstract] [Full Text] [Related]

  • 11. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
    Dalbagni G, Presti JC, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C.
    Diagn Mol Pathol; 1993 Mar 15; 2(1):4-13. PubMed ID: 7904525
    [Abstract] [Full Text] [Related]

  • 12. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.
    Olumi AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bender LI, Jones PA.
    Cancer Res; 1990 Nov 01; 50(21):7081-3. PubMed ID: 2208176
    [Abstract] [Full Text] [Related]

  • 13. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG, Jones PA.
    Cancer Res; 1990 Jan 01; 50(1):44-7. PubMed ID: 2293558
    [Abstract] [Full Text] [Related]

  • 14. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
    Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA.
    Genes Chromosomes Cancer; 1999 Oct 01; 26(2):171-5. PubMed ID: 10469456
    [Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
    Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y.
    J Urol; 1996 Apr 01; 155(4):1444-7. PubMed ID: 8632608
    [Abstract] [Full Text] [Related]

  • 16. Molecular genetic alterations in superficial and locally advanced human bladder cancer.
    Presti JC, Reuter VE, Galan T, Fair WR, Cordon-Cardo C.
    Cancer Res; 1991 Oct 01; 51(19):5405-9. PubMed ID: 1680549
    [Abstract] [Full Text] [Related]

  • 17. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
    Paterson RF, Ulbright TM, MacLennan GT, Zhang S, Pan CX, Sweeney CJ, Moore CR, Foster RS, Koch MO, Eble JN, Cheng L.
    Cancer; 2003 Nov 01; 98(9):1830-6. PubMed ID: 14584063
    [Abstract] [Full Text] [Related]

  • 18. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
    Knowles MA, Shaw ME, Proctor AJ.
    Oncogene; 1993 May 01; 8(5):1357-64. PubMed ID: 8097582
    [Abstract] [Full Text] [Related]

  • 19. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.
    Dahse R, Gärtner D, Werner W, Schubert J, Junker K.
    Oncol Rep; 2003 May 01; 10(6):2033-7. PubMed ID: 14534739
    [Abstract] [Full Text] [Related]

  • 20. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
    Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG, Czerniak B.
    Oncogene; 1997 May 01; 14(17):2059-70. PubMed ID: 9160886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.